GE HealthCare Technologies (GEHC) Consolidated Net Income (2022 - 2026)
GE HealthCare Technologies (GEHC) posted Consolidated Net Income of $411.0 million for Q1 2026, down 31.73% on a QoQ basis from $602.0 million in Q4 2025, and down 30.1% year-over-year from $588.0 million in Q1 2025.
GE HealthCare Technologies (GEHC) Consolidated Net Income (2022 - 2026) Analysis & Trends
GE HealthCare Technologies' Consolidated Net Income history runs 5 years deep, the most recent figure standing at $411.0 million for Q1 2026.
- Quarterly Consolidated Net Income fell 30.1% year-over-year to $411.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 billion (up 93.26% YoY) and the FY2023 annual result came in at -$4.0 million, down 122.22% from the prior year.
- Consolidated Net Income was $411.0 million for Q1 2026 at GE HealthCare Technologies, down from $602.0 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $602.0 million in Q4 2025 and bottomed at -$4.0 million in Q3 2023.
- A 5-year average of $348.9 million and a median of $406.5 million in 2022 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2025 — Consolidated Net Income jumped 51.55% — and 2026, when it slumped 30.1%.
- GE HealthCare Technologies' Consolidated Net Income stood at $6.0 million in 2022, then slumped by 166.67% to -$4.0 million in 2023, then jumped by 10975.0% to $435.0 million in 2024, then surged by 38.39% to $602.0 million in 2025, then plunged by 31.73% to $411.0 million in 2026.
- Business Quant data shows GEHC's Consolidated Net Income at $411.0 million in Q1 2026, $602.0 million in Q4 2025, and $464.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn | 273.95 Mn |
| 10 | Steris | 21.52 Bn | 21.08 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 411.00 Mn |
| Dec 31, 2025 | 602.00 Mn |
| Sep 30, 2025 | 464.00 Mn |
| Jun 30, 2025 | 500.00 Mn |
| Mar 31, 2025 | 588.00 Mn |
| Jun 30, 2024 | 435.00 Mn |
| Mar 31, 2024 | 388.00 Mn |
| Sep 30, 2023 | -4.00 Mn |
| Mar 31, 2023 | 383.00 Mn |
| Dec 31, 2022 | 6.00 Mn |
| Jun 30, 2022 | 12.00 Mn |
| Mar 31, 2022 | 402.00 Mn |